Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-25-002050)

Filing Details

Accession Number:: 0001104659-25-002050
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-01-08 16:30:38
Reporting Period:: 2025-01-06

Accepted Time:: 2025-01-08 16:30:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1736243	Acurx Pharmaceuticals Inc.	ACXP	Pharmaceutical Preparations (2834)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1127423	J Robert Deluccia	C/O Acurx Pharmaceuticals, Inc., 259 Liberty Avenue Staten Island NY 10305		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-01-06	49,261	$1.02	1,010,196	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants for Common Stock	Acquisiton	2025-01-06	49,261	$0.00	49,261	$0.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
49,261	2025-01-07	2030-01-07	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,847	Indirect	By spouse

Footnotes

Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.